Cephalexin 500 mg TID for 7 Days: Appropriate Dosing
Yes, cephalexin 500 mg three times daily (TID) for seven days is an appropriate and effective regimen for an 81-year-old man with normal renal function when treating a susceptible pathogen. This dosing strategy is supported by both FDA labeling and clinical evidence, though the specific indication matters for optimal treatment duration.
Dosing Frequency: TID vs QID
The traditional FDA-approved dosing for cephalexin is 250-500 mg four times daily (QID) 1. However, substantial clinical evidence supports three times daily dosing as equally effective:
For skin and soft tissue infections (SSTIs): Multiple IDSA guidelines recommend cephalexin 500 mg QID for methicillin-susceptible Staphylococcus aureus (MSSA) infections 2, 3. However, a landmark 1981 study demonstrated that cephalexin administered twice daily was equally effective (>97% cure rate) as four times daily dosing for staphylococcal and streptococcal skin infections 4.
For urinary tract infections (UTIs): Recent high-quality evidence shows cephalexin 500 mg twice daily is non-inferior to four times daily dosing. A 2023 multicenter study found no difference in treatment failure between BID (12.7%) and QID (17%) regimens for uncomplicated UTIs 5. A 2025 emergency department study similarly found no statistical difference in treatment failure rates (18.7% BID vs 15.0% QID) 6.
The three times daily regimen you propose sits between these validated frequencies and is clinically reasonable, particularly given that less frequent dosing improves adherence without compromising efficacy.
Duration: Seven Days
Seven-day treatment duration is appropriate for most common infections:
- SSTIs: Standard duration is 5-7 days for uncomplicated infections 3
- UTIs: While 3-5 days may suffice for uncomplicated cystitis 7, seven days is reasonable for an 81-year-old male (who by definition has complicated UTI due to male anatomy)
- Other indications: Most susceptible infections respond within 7-10 days 1
Special Considerations for an 81-Year-Old
Renal Function Monitoring
Critical caveat: While you state normal renal function, the FDA label specifically warns that cephalexin "is known to be substantially excreted by the kidney, and the risk of toxic reactions may be greater in patients with impaired renal function" 1. In elderly patients:
- Serum creatinine may appear normal despite reduced GFR due to decreased muscle mass
- Calculate creatinine clearance (Cockcroft-Gault) to confirm true renal function
- If CrCl <50 mL/min, dose adjustment may be needed despite "normal" creatinine
Drug Interactions
Monitor for metformin interaction if applicable—cephalexin increases metformin levels by 24-34% 1.
Clinical Algorithm for Cephalexin Dosing
For susceptible pathogens with confirmed sensitivity:
- Verify renal function: Calculate CrCl, not just serum creatinine
- If CrCl ≥50 mL/min: 500 mg TID is appropriate
- Duration:
- Uncomplicated SSTI: 5-7 days
- Complicated UTI (males): 7 days minimum
- Bone/joint infections: Longer courses needed (not applicable here)
- Monitor: Gastrointestinal symptoms (most common adverse effect), neutropenia (rare but documented) 8
Common Pitfalls to Avoid
- Don't assume normal creatinine = normal renal function in elderly patients
- Don't use empirically for serious infections—cephalexin is a narrow-spectrum agent best reserved for confirmed susceptible organisms
- Don't use for MRSA—cephalexin has no activity against methicillin-resistant staphylococci 3
- Document the indication on the prescription—only 23% of prescriptions had documented indications in one audit 9
Bottom line: Your proposed regimen of cephalexin 500 mg TID for 7 days is clinically sound for this patient with confirmed susceptibility and verified normal renal function, offering a balance between efficacy and improved adherence compared to QID dosing.